EMA
guidance
· 2013-10-25
Restrictions on use of short-acting beta-agonists in obstetric indications – CMDh endorses PRAC recommendations
Summary
EU CMDh endorses PRAC recommendations to restrict use of short-acting beta-agonists for obstetric indications, signaling updated regulatory guidance on safe use…
Upgrade for the full analysis, importance score, and drug timeline.